PubRank

Dennis H Kraus

Author PubWeight™ 93.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 2005 2.75
2 Prospective functional voice assessment in patients undergoing thyroid surgery. Ann Surg 2002 2.08
3 Primary mucosal malignant melanoma of the head and neck. Head Neck 2002 2.07
4 Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid 2014 2.04
5 Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm. J Clin Oncol 2006 1.97
6 Craniofacial surgery for malignant skull base tumors: report of an international collaborative study. Cancer 2003 1.94
7 Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 2005 1.82
8 Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2011 1.80
9 Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys 2010 1.77
10 Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer. J Nucl Med 2008 1.65
11 Analysis of prognostic factors in 146 patients with anterior skull base sarcoma: an international collaborative study. Cancer 2007 1.63
12 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med 2006 1.46
13 Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancer. Cancer J 2006 1.42
14 Complications of craniofacial resection for malignant tumors of the skull base: report of an International Collaborative Study. Head Neck 2005 1.39
15 Decision making in the management of recurrent head and neck cancer. Head Neck 2013 1.31
16 Craniofacial resection for malignant paranasal sinus tumors: Report of an International Collaborative Study. Head Neck 2005 1.31
17 Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer 2009 1.30
18 Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience. Int J Radiat Oncol Biol Phys 2006 1.29
19 Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma. Cancer 2006 1.28
20 Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers. Int J Radiat Oncol Biol Phys 2008 1.27
21 Improved outcomes in patients with osteogenic sarcoma of the head and neck. Cancer 2002 1.26
22 Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial. Int J Radiat Oncol Biol Phys 2010 1.25
23 Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx. Arch Otolaryngol Head Neck Surg 2006 1.25
24 Lymph node density is a significant predictor of outcome in patients with oral cancer. Cancer 2009 1.20
25 Effects of transforming growth factor-beta1 on human vocal fold fibroblasts. Ann Otol Rhinol Laryngol 2009 1.18
26 Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes. Int J Radiat Oncol Biol Phys 2011 1.17
27 Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience. Int J Radiat Oncol Biol Phys 2007 1.16
28 Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities. Int J Radiat Oncol Biol Phys 2008 1.15
29 Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol 2011 1.14
30 Effects of therapy on dentofacial development in long-term survivors of head and neck rhabdomyosarcoma: the memorial sloan-kettering cancer center experience. J Pediatr Hematol Oncol 2003 1.12
31 The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue. Clin Cancer Res 2003 1.11
32 Fine-needle aspiration biopsy of salivary gland lesions in a selected patient population. Arch Otolaryngol Head Neck Surg 2004 1.08
33 Outcome of craniofacial surgery in children and adolescents with malignant tumors involving the skull base: an international collaborative study. Head Neck 2009 1.08
34 The role of pectoralis major muscle flap in salvage total laryngectomy. Arch Otolaryngol Head Neck Surg 2009 1.07
35 Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx. Head Neck 2005 1.05
36 Anterior cranial base reconstruction using free tissue transfer: changing trends. Head Neck 2003 1.04
37 Five hundred patients with Merkel cell carcinoma evaluated at a single institution. Ann Surg 2011 1.04
38 Craniofacial surgery for esthesioneuroblastoma: report of an international collaborative study. J Neurol Surg B Skull Base 2012 1.02
39 Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma. Head Neck 2010 1.00
40 Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer. Int J Cancer 2013 0.96
41 Complications after craniofacial resection for malignant tumors: are complication trends changing? Otolaryngol Head Neck Surg 2009 0.95
42 Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma. Cancer 2011 0.95
43 Predictors of outcome for advanced-stage supraglottic laryngeal cancer. Head Neck 2009 0.94
44 Patterns and incidence of neural invasion in patients with cancers of the paranasal sinuses. Arch Otolaryngol Head Neck Surg 2009 0.93
45 Radiotherapy after surgical resection for head and neck mucosal melanoma. Am J Clin Oncol 2010 0.92
46 Analysis of postoperative complications of open partial laryngectomy. Head Neck 2009 0.91
47 Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynx. Ann Surg 2003 0.90
48 Predictors of survival and recurrence after temporal bone resection for cancer. Head Neck 2011 0.90
49 Correlation of a priori DCE-MRI and (1)H-MRS data with molecular markers in neck nodal metastases: Initial analysis. Oral Oncol 2012 0.90
50 Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland. Cancer 2009 0.89
51 Selective neck dissection in node-positive squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 2012 0.89
52 Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity. Head Neck 2008 0.88
53 Outcome of craniofacial resection in patients 70 years of age and older. Head Neck 2007 0.88
54 Acinic cell carcinoma of the parotid gland presenting as an external auditory canal mass. Head Neck 2004 0.88
55 Nomograms for preoperative prediction of prognosis in patients with oral cavity squamous cell carcinoma. Cancer 2013 0.88
56 Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. J Clin Oncol 2004 0.86
57 Craniofacial resection for malignant melanoma of the skull base: report of an international collaborative study. Arch Otolaryngol Head Neck Surg 2006 0.86
58 Cyclooxygenase-2 signaling in vocal fold fibroblasts. Laryngoscope 2010 0.85
59 Postoperative management of differentiated thyroid cancer. Otolaryngol Clin North Am 2003 0.85
60 Outcomes of temporal bone resection for locally advanced parotid cancer. Skull Base 2011 0.85
61 Type I thyroplasty for acute unilateral vocal fold paralysis following intrathoracic surgery. Ann Otol Rhinol Laryngol 2002 0.84
62 In vivo and in vitro models of ionizing radiation to the vocal folds. Head Neck 2010 0.83
63 The effects of cigarette smoke condensate on vocal fold transepithelial resistance and inflammatory signaling in vocal fold fibroblasts. Laryngoscope 2011 0.83
64 Cortical activation during swallowing rehabilitation maneuvers: a functional MRI study of healthy controls. Laryngoscope 2010 0.83
65 Measuring quality of life in dysphonic patients: a systematic review of content development in patient-reported outcomes measures. J Voice 2009 0.83
66 Sentinel lymph node biopsy for cutaneous head and neck melanomas. Arch Otolaryngol Head Neck Surg 2002 0.82
67 Outcomes of primary and secondary tracheoesophageal puncture: a 16-year retrospective analysis. Ear Nose Throat J 2006 0.82
68 Craniofacial resection for malignant tumors involving the skull base in the elderly: an international collaborative study. Cancer 2010 0.82
69 Prostaglandin (PG)E2 exhibits antifibrotic activity in vocal fold fibroblasts. Laryngoscope 2011 0.82
70 Tracheostomal and cervical esophageal reconstruction with combined deltopectoral flap and microvascular free jejunal transfer after central neck exenteration. Plast Reconstr Surg 2005 0.82
71 First bite syndrome: incidence, risk factors, treatment, and outcomes. Laryngoscope 2012 0.81
72 Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer. Am J Clin Oncol 2008 0.81
73 Preliminary evaluation of the reliability and validity of the Shame and Stigma Scale in head and neck cancer. Head Neck 2012 0.81
74 Glucocorticoids regulate extracellular matrix metabolism in human vocal fold fibroblasts. Laryngoscope 2011 0.81
75 The current status of positron-emission tomography scanning in the evaluation and follow-up of patients with head and neck cancer. Curr Opin Otolaryngol Head Neck Surg 2006 0.80
76 Cigarette smoke and reactive oxygen species metabolism: implications for the pathophysiology of Reinke's edema. Laryngoscope 2009 0.80
77 Endoscopic skull base surgery practice patterns: survey of the North American Skull Base Society. Int Forum Allergy Rhinol 2013 0.80
78 Minimally invasive video-assisted thyroidectomy 2.0: expanded indications in a tertiary care cancer center. Head Neck 2010 0.79
79 Craniofacial surgery for nonmelanoma skin malignancy: report of an international collaborative study. Head Neck 2007 0.79
80 Long-term results of three-dimensional conformal radiation therapy for patients with rhabdomyosarcoma. Cancer 2003 0.79
81 Event-related functional MRI investigation of vocal pitch variation. Neuroimage 2008 0.78
82 Recurrent laryngeal cancer presenting as delayed hypoparathyroidism. Head Neck 2007 0.77
83 Improvement in survival during the past 4 decades among patients with anterior skull base cancer. Head Neck 2011 0.77
84 Radiotherapy in the multimodal treatment of extrarenal extracranial malignant rhabdoid tumors. Pediatr Blood Cancer 2008 0.77
85 Sentinel lymph node biopsy versus selective neck dissection for detection of metastatic oral squamous cell carcinoma. Clin Exp Metastasis 2012 0.76
86 Results of anterior skull base surgery in pediatric and young adult patients. Skull Base 2010 0.76
87 Outcome of resection of infratemporal fossa tumors. Head Neck 2013 0.76
88 Cancer of the nasal cavity and paranasal sinuses. Expert Rev Anticancer Ther 2004 0.75
89 Murine model of neuromuscular electrical stimulation on squamous cell carcinoma: potential implications for dysphagia therapy. Head Neck 2011 0.75
90 Secondary skull base malignancies in survivors of retinoblastoma: the memorial sloan kettering cancer center experience. Skull Base 2011 0.75
91 Advanced head and neck cancer-surgery and reconstruction. Cancer Treat Res 2003 0.75
92 TALK score: Development and validation of a prognostic model for predicting larynx preservation outcome. Laryngoscope 2012 0.75
93 Positron-emission tomography enhancement after vocal fold injection medialization. Ear Nose Throat J 2017 0.75
94 Correlation between functional MRI and voice improvement following Type I thyroplasty in unilateral vocal fold paralysis--a case study. J Voice 2008 0.75
95 Clinical ethics consultation in patients with head and neck cancer. Head Neck 2012 0.75
96 Functional imaging in head and neck cancer. Curr Oncol Rep 2005 0.75
97 Applicability of lymphoscintigraphy with sentinel node biopsy to eccrine carcinoma of the head and neck. Head Neck 2003 0.75